Syverson Strege & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Buy |
+4,356
| New | +$345K | 0.08% | 102 |
|
|
2023
Q2 | – | Sell |
-686
| Closed | -$73K | – | 407 |
|
|
2023
Q1 | $73K | Buy |
686
+3
| +0.4% | +$319 | 0.03% | 105 |
|
|
2022
Q4 | $75.8K | Buy |
683
+4
| +0.6% | +$444 | 0.03% | 106 |
|
|
2022
Q3 | $58K | Sell |
679
-226
| -25% | -$19.3K | 0.03% | 115 |
|
|
2022
Q2 | $82K | Buy |
905
+233
| +35% | +$21.1K | 0.03% | 107 |
|
|
2022
Q1 | $55K | Buy |
672
+4
| +0.6% | +$327 | 0.06% | 117 |
|
|
2021
Q4 | $51K | Buy |
668
+3
| +0.5% | +$229 | 0.04% | 133 |
|
|
2021
Q3 | $50K | Buy |
665
+4
| +0.6% | +$301 | 0.04% | 142 |
|
|
2021
Q2 | $51K | Sell |
661
-104
| -14% | -$8.02K | 0.05% | 132 |
|
|
2021
Q1 | $56K | Buy |
765
+518
| +210% | +$37.9K | 0.06% | 112 |
|
|
2020
Q4 | $19K | Buy |
+247
| New | +$19K | 0.02% | 155 |
|